Results 201 to 210 of about 67,791 (261)

Buprenorphine: critical questions examined. [PDF]

, 2005
Buning, Ernst, Verster, Annette
core  

Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder. [PDF]

Addict Sci Clin Pract
Azar P, Schneiderman H, Barron H, Wong JSH, Meyer M, Newman-Azar D, Narimani M, Ignaszewski MJ, Mathew N, Mullen R, Krausz RM, Maharaj AR.   +11 more
europepmc   +1 more source

Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel [PDF]

, 2018
Besson, Jacques, Burnand, Bernard, Eastus, Christopher, Eggenberger, Christina, Hämmig, Robert, Vader, John-Paul   +5 more
core  

Executive function at baseline and follow-up in opioid maintenance patients and its relation to psychiatric comorbidity and substance use patterns. [PDF]

BMC Psychiatry
Högberg JH, Philips B, Nielsen J, Simsek SR, Berglund K.   +4 more
europepmc   +1 more source

Effect of Group Motivational Enhancement Therapy in Patients with Opioid Dependence (on Maintenance Treatment): Study Protocol of a Randomized Controlled Trial. [PDF]

Indian J Psychol Med
Mishra S, Kar SK, Singh A, Nischal A, Agarwal V.   +4 more
europepmc   +1 more source

Strategies for treating acute pain in patients with opioid dependence: a scoping review protocol. [PDF]

BMJ Open
Levine S, Andrews M, Saracco B, Salzman M.   +3 more
europepmc   +1 more source

Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.

JAMA Netw Open
Ross RK, Inose S, Shulman M, Nunes EV, Zalla LC, Burlew AK, Rudolph KE.   +6 more
europepmc   +1 more source

Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.

JAMA Netw Open
Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS.   +11 more
europepmc   +1 more source